TAGline November 2022
This year’s edition of TAGline commemorates TAG’s 30th anniversary, and these articles explore TAG’s work over the years: what we've accomplished, what we've learned, the continuing obstacles to progress, and what comes next.
Treatment Action Group Statement: U.S. District Court Ruling Allowing Employers to Deny PrEP Coverage Is a Dangerous Attack on Public Health
Treatment Action Group (TAG) unequivocally condemns the September 2022 U.S. District Court ruling in Fort Worth, Texas on the case Braidwood Management Inc. et al., v. Xavier Becerra et al., which ruled that the Affordable Care Act’s requirement that employers cover pre-exposure prophylaxis (PrEP) for HIV prevention was unconstitutional.
Submission to the Office of the High Commissioner for Human Rights Input to HRC resolution 47/17
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on 'human rights in the context of HIV/AIDS' (HRC resolution 47/17).
Treatment Action Group Condemns Reported Bullying, Harassment, and Racism at Stop TB Partnership
Treatment Action Group (TAG) strongly condemns alleged bullying, harassment, and racism directed toward staff and contractors of the Stop TB Partnership, as reported by The New York Times. As a long-term and current grantee of the Stop TB Partnership, we stand in solidarity with current and former staff and contractors whom this harassment and racism has affected.
Ensuring Universal Access to COVID-19 Diagnosis, Treatment and Prevention
TAG and the Center for Economic and Social Rights produced this joint publication, as part of CESR’s COVID-19 “Recovering Rights” series of briefs.
Civil Rights Groups, Health Advocates, and Public Defenders Celebrate Passage of Legislation to Protect Contact Tracing Data from Law Enforcement
TAG is one of the organizations who supports confidentiality in contact tracing and is applauding the passage of this legislation. As TAG's State and Local Policy Director Annette Gaudino says in this statement, “There can be no effective contact tracing without trust.”
Statement on Human Challenge Studies for COVID-19 Vaccine Development
Two recent developments have brought renewed publicity to proposals to conduct human challenge studies to test COVID-19 vaccine candidates: an open letter from the organization 1DaySooner and media reports that Adrian Hill’s Oxford University research group is planning a challenge study, taking advantage of the lack of regulatory oversight of human challenge experiments in the United Kingdom.
Treatment Action Group Mourns and Resists Violence towards Black Communities; Demands Action and Accountability across Government and Systems
Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.
AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies
The COVID-19 pandemic is a global health emergency that may demand new, safe, and expedited ways of conducting ethical research to find the solutions we need, including a safe and effective vaccine.
Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis
AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.